The present work aims to develop and evaluate the wound healing potential of bakuchiol nanoemulsion loaded electrospun scaffolds. Since oxidative stress and microbial burden leads the burn wounds to become chronic and fatal to patients, a phytoconstituent, bakuchiol (BAK), was screened on the basis of antioxidant and antimicrobial potential which also defined its dose. Furthermore, BAK was incorporated into a nanoemulsion to enhance its therapeutic efficacy, reduce its dosage frequency, and maximize its stability. The present study is inclined towards the collaborative interaction of natural products and novel drug delivery systems to develop safe and therapeutically efficient systems for burn wound healing. The optimized nanoemulsion showed excellent antioxidant and antimicrobial potential against wound susceptible pathogens, i.e., Candida albicans and Methicillin-resistant Staphylococcus aureus which was further loaded into gelatin based hydrogel and nanofibrous scaffold system. The mesh structure of scaffolds was chosen as a suitable carrier system for wound healing process not only because it offers resemblance to skin's anatomy but is also capable of providing uniform distribution of wound biomarkers across the skin. The prepared nanofibers were assessed for their analgesic, anti-inflammatory, and wound healing potential which was observed to be significantly better than its gel formulation.
Keyphrases
- wound healing
- anti inflammatory
- oxidative stress
- tissue engineering
- candida albicans
- methicillin resistant staphylococcus aureus
- staphylococcus aureus
- end stage renal disease
- drug delivery
- chronic kidney disease
- ischemia reperfusion injury
- ejection fraction
- newly diagnosed
- risk factors
- diabetic rats
- prognostic factors
- spinal cord injury
- microbial community
- cystic fibrosis
- peritoneal dialysis
- pseudomonas aeruginosa
- gram negative
- signaling pathway
- combination therapy
- neuropathic pain
- patient reported outcomes
- risk assessment
- endoplasmic reticulum stress
- antimicrobial resistance
- replacement therapy